House dust mite allergen causes certain features of steroid resistant asthma in high fat fed obese mice

Int Immunopharmacol. 2018 Feb:55:20-27. doi: 10.1016/j.intimp.2017.11.014. Epub 2017 Dec 22.

Abstract

Obesity is a high risk factor for diseases such as cardiovascular, metabolic syndrome and asthma. Obese-asthma is another emerging phenotype in asthma which is typically refractive to steroid treatment due to its non-classical features such as non-eosinophilic cellular inflammation. The overall increased morbidity, mortality and economical burden in asthma is mainly due to steroid resistant asthma. In the present study, we used high fat diet induced obese mice which when sensitized with house dust mite (HDM) showed steroid resistant features. While the steroid, dexamethasone (DEX), treatment to high fat fed naïve mice could not reduce the airway hyperresponsiveness (AHR) induced by high fat, DEX treatment to high fat fed allergic mice could not reduce the HDM allergen induced airway remodeling features though it reduced airway inflammation. Further, these HDM induced high fat fed mice with or without DEX treatment had shown the increased activity and expression of arginase as well as the inducible nitric oxide synthase (iNOS) expression. However, DEX treatment had reduced the expressions of high iNOS and arginase I in control chow diet fed mice. Thus, we speculate that the steroid resistance seen in human obese asthmatics could be stemming from altered NO metabolism and its induced airway remodeling and with further investigations, it would encourage new treatments specific to obese-asthma phenotype.

Keywords: Airway inflammation; Airway remodeling; Arginase; Obese-asthma; iNOS.

MeSH terms

  • Airway Remodeling / drug effects*
  • Animals
  • Antigens, Dermatophagoides / immunology
  • Arginase / genetics
  • Arginase / metabolism
  • Asthma / drug therapy*
  • Dexamethasone / therapeutic use*
  • Diet, High-Fat
  • Drug Resistance
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Obesity / drug therapy*
  • Pyroglyphidae / immunology
  • Respiratory Hypersensitivity / drug therapy*

Substances

  • Antigens, Dermatophagoides
  • Nitric Oxide
  • Dexamethasone
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Arginase